4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Wai Yuen Tong Medicine Holdings Limited (0897) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Kowloon Bay, Hong Kong with about 691 employees. Its market capitalization is roughly HKD 318 million. In the fiscal year ended 2026-03-31, 0897 reported HKD 683M in revenue and HKD 4M in net income.
Wai Yuen Tong Medicine Holdings Limited, an investment holding company, engages in production and sale of Chinese and western pharmaceuticals and health food products in Mainland China and Hong Kong.
Interactive charts & full statements →
| Income statement | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Revenue | HKD 683M | HKD 745M | HKD 784M | HKD 724M | — |
| Gross Profit | HKD 362M | HKD 376M | HKD 395M | HKD 342M | — |
| Operating Income (EBIT) | (HKD 17M) | (HKD 32M) | HKD 40M | HKD 12M | — |
| Net Income | HKD 4M | HKD 7M | (HKD 15M) | (HKD 20M) | — |
HKD; HKDM / HKDB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Dividends Paid | — | (HKD 199M) | — | — | — |
HKD; HKDM / HKDB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Assets | HKD 1.6B | HKD 1.7B | HKD 2.1B | HKD 7.0B | — |
| Total Liabilities | HKD 446M | HKD 556M | HKD 710M | HKD 3.3B | — |
HKD; HKDM / HKDB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 0897 viewer.
About TickerBase · Data methodology & sources · Privacy · Terms